TERTIAPIN Q
Product ID L8406-500UG 
Name TERTIAPIN Q 
Molecular formula C106H175N35O24S4
Description
A 21 amino-acids peptide with 2 disulfide bridges , synthetic, initially isolated from the venom of the European honey bee Apis mellifera.
Biological activity

Tertiapin has been isolated from the venom of the Honeybee Apis mellifera. Tertiapin-Q is an oxidation-resistant mutant of the wild-type tertiapin where Methionine 13 has been replaced by a Glutamine. Tertiapin-Q blocks the inwardly rectifying Kir1.1 (ROMK1) and Kir3.1/3.4 (GIRK1/GIRK4 also known as IKACh) potassium channels with Kd values of around 2 nM and 8 nM respectively.Tertiapin-Q also inhibits calcium-activated large conductance BK potassium channels (KCa1.1) in a concentration and voltage-dependent manner (IC50 ~ 5 nM), in addition to inhibiting Kir3.1/3.2 (GIRK1/GIRK2) heteromultimer potassium channels with a Kd close to 270 nM. Tertiapin-Q can prevent dose-dependent acetylcholine(ACh)-induced atrioventricular blocks in mammalian hearts, as KCNJ3/KCNJ5 channels (also named I(KACh)), are activated by ACh found in mammalian myocytes.

 Packaging and Prices

Packaging Price (€) Quantité Buy Now
1 Unité(s) 120.00

add to cart add to cart

5 Unité(s) 480.00

add to cart add to cart

For quotation of big quantities, please Contact us
 Product Technical Documents
Safety Data Sheet Available on request, please Contact us
Ref. SDS_L8406-500UG : unit price : free of charge
 Chemical and Physical Properties
Product code L8406-500UG  Molecular weight 2452 Da
Product name TERTIAPIN Q  Physical form White lyophilized solid
CAS No. 252198-49-5 Melting point
RTECS NA Solubility water and saline buffer
UNIPROT P56587 Optical Activity
PubChem SID    
PubChem CID 90479782    
Purity > 98 %    
Toxicity(LD50) No Data    
Chemical Name    
Storage & Reconstitution
Recommandations

Stable at room temperature, store preferably at 4°C


 
Savety Recommandations  
 Bibliographic References
Product code L8406-500UG 
Product name TERTIAPIN Q 

- 1. Felix, J. P.,et al. (2006) Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapin,Biochemistry.  ;
2. Jin, W., et al. (1999) Mechanisms of inward-rectifier K+ channel inhibition by tertiapin-Q, Biochemistry.   ;
3. Jin, W., and Lu, Z. (1999) Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels, Biochemistry.  ;
4. Kanjhan, R., C et al. (2005) Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner, J Pharmacol Exp Ther.  ;
5. Kitamura, H., et al. (2000) Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes, J Pharmacol Exp Ther.  ;
6. Ramu, Y., et al. (2001) Titration of tertiapin-Q inhibition of ROMK1 channels by extracellular protons, Biochemistry.
 Links
Product code L8406-500UG 
Product name TERTIAPIN Q 
External Links PubMed
Biomedical Citations From PubMed
Toxicology Citations From PubMed
PubChem CID
UNIPROT
click to zoom

LOGIN
Welcome, click here to   Login !




Adress:
ZA Les Auréats, 845 Avenue Pierre Brossolette
26800 PORTES lès VALENCE - FRANCE

Phone:
+33 475 419 191

Email:
latoxan[@]latoxan.com

Web link:
www.latoxan.com